BioSpace News Archive

Drug Development

vTv Therapeutics Initiates Patient Dosing In The AGATA Study, A Six Month Phase 2 Study Evaluating TTP399, A Liver-Selective Glucokinase Activator, For The Treatment Of Type 2 Diabetes

June 5, 2015
·
5 min read
Drug Development

First Patient Enrolled In Pivotal Therapeutics Inc.'s POMEGA Phase IIa Clinical Trial With PVT-100

June 5, 2015
·
4 min read
BioMidwest

New Inspire Medical Systems Upper Airway Stimulation Therapy 18-Month Durability Research Shows Sustained Reductions In Obstructive Sleep Apnea (OSA) Severity, Improvement In Quality Of Life

June 5, 2015
·
3 min read
Drug Development

Synageva BioPharma Completes Targeted Enrollment In Phase 1/2 Trial With SBC-103 For Mucopolysaccharidosis IIIB

June 5, 2015
·
6 min read
Policy

Syneron Medical Ltd. And Viora Announce Settlement Agreement Of Business And Patent Litigations

June 5, 2015
·
4 min read
MERS And Ebola Replikins Synthetic Vaccine-Blocker Candidates Presented At Meeting Of Int’l Society For Neglected Tropical Diseases At Wellcome Trust May 20th

June 5, 2015
·
1 min read
EndoChoice Announces Pricing Of Its Initial Public Offering

June 5, 2015
·
2 min read
Endo International Prices Offering Of 24,024,025 Ordinary Shares

June 5, 2015
·
5 min read
Business

Isis Pharma’ License Agreement With Bayer For ISIS-FXI Rx Receives Hart-Scott-Rodino Approval

June 5, 2015
·
5 min read
Pharm Country

TAXIS Pharmaceuticals, Inc. Announces Publication Of Data Demonstrating Potential Viability Of TXA709 In Combating Antibiotic Resistance

June 5, 2015
·
4 min read